Daratumumab plus Lenalidomide/ dexamethasone in transplant-neligible patients with newly diagnosed multiple myeloma: MAIA update

被引：0

作者：

Basu, Supratik ^{[1
]}

Kumar, Shaji K. ^{[2
]}

Moreau, Philippe ^{[3
]}

Bahlis, Nizar ^{[4
]}

Facon, Thierry ^{[5
]}

Plesner, Torben ^{[6
,7
]}

Orlowski, Robert Z. ^{[8
]}

Nahi, Hareth ^{[9
]}

Hulin, Cyrille ^{[10
]}

Quach, Hang ^{[11
]}

Goldschmidt, Hartmut ^{[12
]}

O'Dwyer, Michael ^{[13
]}

Perrot, Aurore ^{[14
]}

Venner, Christopher P. ^{[15
]}

Weisel, Katja ^{[16
]}

Raje, Noopur ^{[17
]}

Tiab, Mourad ^{[18
]}

Macro, Margaret ^{[19
]}

Frenzel, Laurent ^{[20
]}

Leleu, Xavier ^{[21
]}

Pei, Huiling ^{[22
]}

Krevvata, Maria ^{[23
]}

Borgsten, Fredrik ^{[24
]}

Usmani, Saad Z. ^{[25
]}

机构：

[1] Royal Hosp Wolverhampton, Wolverhampton, England

[2] Mayo Clin Rochester, Dept Haematol, Rochester, MN USA

[3] Univ Hosp Hotel Dieu, Dept Hematol, Nantes, France

[4] Univ Calgary, Arnie Charbonneau Canc Res Inst, Calgary, AB, Canada

[5] Univ Lille, CHU Lille, Serv Malad Sang, Lille, France

[6] Vejle Hosp, Vejle, Denmark

[7] Univ Southern Denmark, Vejle, Denmark

[8] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

[9] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Haematol, Dept Med, Stockholm, Sweden

[10] Univ Hosp Pessac, Dept Haematol, Hop Haut Leveque, Pessac, France

[11] Univ Melbourne, St Vincents Hosp, Melbourne, Australia

[12] Univ Heidelberg Hosp, GMMG Study Grp, Internal Med 5, Heidelberg, Germany

[13] NUI, Dept Med Haematol, Galway, Ireland

[14] UPS, Univ Toulouse, CHU Toulouse, IUCT O,Serv Hematol, Toulouse, France

[15] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada

[16] Univ Med Ctr Hamburg Eppendorf, Haematol & Bone Marrow Transplantat Sect Pneumol, Dept Oncol, Hamburg, Germany

[17] Massachusetts Gen Hosp, Ctr Multiple Myeloma, Canc Ctr, Boston, MA USA

[18] CHD Vendee, La Roche Sur Yon, France

[19] Ctr Hosp Univ CHU Caen, Caen, France

[20] Hop Necker Enfants Malad, Paris, France

[21] Hop Miletrie, CHU Poitiers, Poitiers, France

[22] Janssen Res & Dev LLC, Titusville, NJ USA

[23] Janssen Res & Dev LLC, Spring House, PA USA

[24] Janssen Res & Dev LLC, Raritan, NJ USA

[25] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH23-OR21

引用

页码：17 / 18

页数：2

共 50 条

[41] A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
Sonneveld, Pieter
Dimopoulos, Meletios A.
Boccadoro, Mario
Quach, Hang
Ho, P. Joy
Beksac, Meral
Hulin, Cyrille
Antonioli, Elisabetta
Leleu, Xavier
Mangiacavalli, Silvia
Perrot, Aurore
Cavo, Michele
Belotti, Angelo
Broijl, Annemiek
Gay, Francesca
Mina, Roberto
van de Donk, Niels W. C. J.
Katodritou, Eirini
Schjesvold, Fredrik
Balari, Anna Sureda
Rosinol, Laura
Delforge, Michel
Roeloffzen, Wilfried
Silzle, Tobias
Vangsted, Annette
Einsele, Hermann
Spencer, Andrew
Hajek, Roman
Jurczyszyn, Artur
Lonergan, Sarah
Ahmadi, Tahamtan
Liu, Yanfang
Wang, Jianping
Vieyra, Diego
van Brummelen, Emilie M. J.
Vanquickelberghe, Veronique
Sitthi-Amorn, Anna
de Boer, Carla J.
Carson, Robin
Rodriguez-Otero, Paula
Blade, Joan
Moreau, Philippe
[J]. FUTURE ONCOLOGY, 2024, 20 (38) : 3043 - 3063
[42] Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant
Derman, Benjamin A.
Cooperrider, Jennifer
Rosenblatt, Jacalyn
Avigan, David E.
Rampurwala, Murtuza
Barnidge, David
Major, Ajay
Karrison, Theodore
Jiang, Ken
Ramsland, Aubrianna
Kubicki, Tadeusz
Jakubowiak, Andrzej J.
[J]. BLOOD CANCER JOURNAL, 2024, 14 (01):
[43] Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
Badros, Ashraf
Foster, Laahn
Anderson Jr, Larry D.
Chaulagain, Chakra P.
Pettijohn, Erin
Cowan, Andrew J.
Costello, Caitlin
Larson, Sarah
Sborov, Douglas W.
Shain, Kenneth H.
Silbermann, Rebecca
Shah, Nina
Chung, Alfred
Krevvata, Maria
Pei, Huiling
Patel, Sharmila
Khare, Vipin
Cortoos, Annelore
Carson, Robin
Lin, Thomas S.
Voorhees, Peter
[J]. BLOOD, 2025, 145 (03) : 300 - 310
[44] Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study
Sborov, Douglas W.
Baljevic, Muhamed
Reeves, Brandi
Laubach, Jacob
Efebera, Yvonne A.
Rodriguez, Cesar
Costa, Luciano J.
Chari, Ajai
Silbermann, Rebecca
Holstein, Sarah A.
Anderson, Larry D., Jr.
Kaufman, Jonathan L.
Shah, Nina
Pei, Huiling
Patel, Sharmila
Cortoos, Annelore
Bartlett, J. Blake
Vermeulen, Jessica
Lin, Thomas S.
Voorhees, Peter M.
Richardson, Paul G.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (03) : 355 - 365
[45] Impact of age on efficacy and safety of daratumumab in combination with lenalidomide and dexamethasone (D-Rd) in patients (pts) with transplant-ineligible newly diagnosed multiple myeloma (NDMM): MAIA.
Usmani, Saad Zafar
Facon, Thierry
Kumar, Shaji
Plesner, Torben
Moreau, Philippe
Basu, Supratik
Nahi, Hareth
Macro, Margaret
Quach, Hang
Perrot, Aurore
Venner, Chris
Weisel, Katja
Raje, Noopur S.
Attal, Michel
Leleu, Xavier
Krevvata, Maria
Wang, Jianping
Kobos, Rachel
Hulin, Cyrille
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[46] Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
Gay, Francesca
Hayman, Suzanne R.
Lacy, Martha Q.
Buadi, Francis
Gertz, Morie A.
Kumar, Shaji
Dispenzieri, Angela
Mikhael, Joseph R.
Bergsagel, P. Leif
Dingli, David
Reeder, Craig B.
Lust, John A.
Russell, Stephen J.
Roy, Vivek
Zeldenrust, Steven R.
Witzig, Thomas E.
Fonseca, Rafael
Kyle, Robert A.
Greipp, Philip R.
Stewart, A. Keith
Rajkumar, S. Vincent
[J]. BLOOD, 2010, 115 (07) : 1343 - 1350
[47] Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study
Takamatsu, Hiroyuki
Iida, Shinsuke
Shibayama, Hirohiko
Shibayama, Kazuhiro
Yamazaki, Hiroshi
Suzuki, Kenshi
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (05) : 692 - 701
[48] Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study
Hiroyuki Takamatsu
Shinsuke Iida
Hirohiko Shibayama
Kazuhiro Shibayama
Hiroshi Yamazaki
Kenshi Suzuki
[J]. International Journal of Hematology, 2020, 111 : 692 - 701
[49] A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
Derman, Ben A.
Major, Ajay
Rosenblatt, Jacalyn
Avigan, David
Rampurwala, Murtuza M.
Alcantar, Luis
Libao, Bernadette M.
McIver, Amanda
Andreatos, Evangelia
Major, Sarah
Wolfe, Brittany
Gorski, Martha
Karrison, Theodore G.
Stefka, Andrew
Jakubowiak, Andrzej
[J]. BLOOD, 2021, 138
[50] Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Facon, Thierry
Venner, Christopher P.
Bahlis, Nizar J.
Offner, Fritz
White, Darrell J.
Karlin, Lionel
Benboubker, Lotfi
Rigaudeau, Sophie
Rodon, Philippe
Voog, Eric
Yoon, Sung-Soo
Suzuki, Kenshi
Shibayama, Hirohiko
Zhang, Xiaoquan
Twumasi-Ankrah, Philip
Yung, Godwin
Rifkin, Robert M.
Moreau, Philippe
Lonial, Sagar
Kumar, Shaji K.
Richardson, Paul G.
Rajkumar, S. Vincent
[J]. BLOOD, 2021, 137 (26) : 3616 - 3628

← 1 2 3 4 5 →